Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XYZ vs MRNA✓SelectedUSD · MRNAXYZ vs MRNA performance historyLatest closeAs of-6.05%11/19
Stock and ETF performance explorer

XYZ vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-64.9%
MRNA return
-25.6%
Excess return
-39.2%
Maximum drawdown
-81.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.0%+1.3%-7.3%-6.2%
7D-9.8%-13.8%+4.1%-8.0%
30D-5.0%-17.7%+12.7%-2.7%
3M-8.3%+14.3%-22.6%-11.1%
6M+7.3%+336.0%-328.7%-28.9%
YTD+14.0%+575.9%-561.9%-36.3%
1Y+19.7%+724.4%-704.6%-38.0%
3Y+27.6%+160.8%-133.2%-16.4%
All-64.9%-25.6%-39.2%-66.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling